Michel Pelat

1.3k total citations
27 papers, 1.1k citations indexed

About

Michel Pelat is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Michel Pelat has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Cardiology and Cardiovascular Medicine and 10 papers in Physiology. Recurrent topics in Michel Pelat's work include Receptor Mechanisms and Signaling (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Heart Rate Variability and Autonomic Control (7 papers). Michel Pelat is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Heart Rate Variability and Autonomic Control (7 papers). Michel Pelat collaborates with scholars based in France, Belgium and United States. Michel Pelat's co-authors include Jean‐Luc Balligand, Paul Massion, Olivier Féron, Chantal Dessy, Catharina Belge, Jean‐Pierre Desager, Nadia Hedhli, Fanny Desjardins, Jean‐Michel Sénard and Patrick Verwaerde and has published in prestigious journals such as Circulation, Circulation Research and Annals of the New York Academy of Sciences.

In The Last Decade

Michel Pelat

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michel Pelat France	15	462	388	322	210	172	27	1.1k
Jodil Willems Netherlands	15	855 1.9×	361 0.9×	411 1.3×	130 0.6×	239 1.4×	19	1.2k
Xinli Hu United States	17	537 1.2×	406 1.0×	235 0.7×	143 0.7×	90 0.5×	20	1.1k
Alex L. Loeb United States	21	492 1.1×	397 1.0×	636 2.0×	126 0.6×	164 1.0×	39	1.5k
Ashraf Abrahani Canada	22	598 1.3×	402 1.0×	246 0.8×	131 0.6×	185 1.1×	25	1.1k
Maengjo Kim United States	13	734 1.6×	417 1.1×	256 0.8×	180 0.9×	152 0.9×	18	1.2k
Helma van Essen Netherlands	22	374 0.8×	480 1.2×	291 0.9×	87 0.4×	136 0.8×	55	1.3k
Haruki Yamakawa Japan	18	656 1.4×	232 0.6×	158 0.5×	120 0.6×	103 0.6×	41	1.5k
C L Seidel United States	20	423 0.9×	339 0.9×	258 0.8×	89 0.4×	163 0.9×	41	1.0k
Wataru Mizushima Japan	21	813 1.8×	376 1.0×	286 0.9×	273 1.3×	111 0.6×	29	1.4k
Alessia Bagattin Italy	16	699 1.5×	330 0.9×	185 0.6×	138 0.7×	86 0.5×	19	1.2k

Countries citing papers authored by Michel Pelat

Since Specialization

Citations

This map shows the geographic impact of Michel Pelat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Pelat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Pelat more than expected).

Fields of papers citing papers by Michel Pelat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Pelat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Pelat. The network helps show where Michel Pelat may publish in the future.

Co-authorship network of co-authors of Michel Pelat

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Pelat. A scholar is included among the top collaborators of Michel Pelat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Pelat. Michel Pelat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ozoux, Marie‐Laure, Michel Pelat, Paul Schaeffer, et al.. (2020). Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated Comorbidities. Journal of Pharmacology and Experimental Therapeutics. 374(1). 24–37. 7 indexed citations

Desjardins, Fanny, Irina Lobysheva, Michel Pelat, et al.. (2008). Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis. Cardiovascular Research. 79(3). 527–536. 48 indexed citations

Desjardins, Fanny, Belaïd Sekkali, Wim Verreth, et al.. (2007). Rosuvastatin increases vascular endothelial PPARγ expression and corrects blood pressure variability in obese dyslipidaemic mice. European Heart Journal. 29(1). 128–137. 42 indexed citations

Pelat, Michel, Paul Massion, & Jean‐Luc Balligand. (2005). Nitric oxide "at heart": emerging paradigms after a decade.. PubMed. 98(3). 242–8. 11 indexed citations

Massion, Paul, Michel Pelat, Catharina Belge, & Jean‐Luc Balligand. (2005). Regulation of the mammalian heart function by nitric oxide. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 142(2). 144–150. 94 indexed citations

Belge, Catharina, Paul Massion, Michel Pelat, & Jean‐Luc Balligand. (2005). Nitric Oxide and the Heart: Update on New Paradigms. Annals of the New York Academy of Sciences. 1047(1). 173–182. 40 indexed citations

Hedhli, Nadia, Michel Pelat, & C. Depre. (2005). Protein turnover in cardiac cell growth and survival. Cardiovascular Research. 68(2). 186–196. 44 indexed citations

Desjardins, Fanny, Michel Pelat, Xavier Havaux, et al.. (2004). Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) potentiates postsynaptic vagal inhibition of cardiac contraction in vivo and in vitro. Circulation. 110(17). 111–111. 19 indexed citations

Pelat, Michel & Jean‐Luc Balligand. (2004). Statins and Hypertension. Seminars in Vascular Medicine. 4(4). 367–375. 7 indexed citations

10.

Massion, Paul, Chantal Dessy, Fanny Desjardins, et al.. (2004). Cardiomyocyte-Restricted Overexpression of Endothelial Nitric Oxide Synthase ( NOS3 ) Attenuates β-Adrenergic Stimulation and Reinforces Vagal Inhibition of Cardiac Contraction. Circulation. 110(17). 2666–2672. 91 indexed citations

11.

Pelat, Michel, Patrick Verwaerde, Jean Galitzky, et al.. (2003). High Isoproterenol Doses Are Required to Activate β3-Adrenoceptor-Mediated Functions in Dogs. Journal of Pharmacology and Experimental Therapeutics. 304(1). 246–253. 17 indexed citations

12.

Pelat, Michel, Chantal Dessy, Paul Massion, et al.. (2003). 4P-1061 Altered blood pressure and heart rate variability in hypercholesterolemic apoE-/-mice is corrected by rosuvastatin independently of its plasma lipid lowering activity. Atherosclerosis Supplements. 4(2). 308–308. 1 indexed citations

13.

Pelat, Michel, et al.. (2002). Alpha2-adrenoceptor function in arterial hypertension associated with obesity in dogs fed a high-fat diet. Journal of Hypertension. 20(5). 957–964. 6 indexed citations

14.

Pathak, Atul, Patrick Verwaerde, Michel Galinier, et al.. (2002). [Study of ventricular repolarization in an experimental model of arterial hypertension associated with obesity].. PubMed. 95(7-8). 651–5. 3 indexed citations

15.

Pelat, Michel, Patrick Verwaerde, M. A. Tran, et al.. (2001). Changes in vascular alpha1‐ and alpha2‐adrenoceptor responsiveness by selegiline treatment. Fundamental and Clinical Pharmacology. 15(4). 239–245. 3 indexed citations

16.

Montastruc, Jean‐Louis, Patrick Verwaerde, Michel Pelat, et al.. (1999). Peripheral cardiovascular actions of SR 58611 A, a beta 3‐adrenoceptor agonist, in the dog: lack of central effect. Fundamental and Clinical Pharmacology. 13(2). 180–186. 8 indexed citations

17.

Pelat, Michel, Eric Lazartigues, Claude Gharib, et al.. (1999). Characterization of the central muscarinic cholinoceptors involved in the cholinergic pressor response in anesthetized dogs. European Journal of Pharmacology. 379(2-3). 117–124. 5 indexed citations

18.

Pelat, Michel, Patrick Verwaerde, Jean Galitzky, et al.. (1998). [Twenty-four hour time and frequency domain variability of systolic blood pressure and heart rate in an experimental model of arterial hypertension plus obesity].. PubMed. 91(8). 999–1002. 3 indexed citations

19.

Jl, Montastruc, Michel Pelat, Patrick Verwaerde, et al.. (1998). Fluoxetine in orthostatic hypotension of Parkinson's disease: A clinical and experimental pilot study. Fundamental and Clinical Pharmacology. 12(4). 398–402. 14 indexed citations

20.

Lazartigues, Eric, Jean‐Louis Freslon, Christine Brefel‐Courbon, et al.. (1998). Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat. European Journal of Pharmacology. 361(1). 61–71. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact